{"status": "ok", "totalResults": 1, "articles": [{"source": {"id": null, "name": "Acrofan.com"}, "author": null, "title": "Moderna Files to Expand the Conditional Marketing Authorization for its COVID-19 Vaccine in the European Union to Include Children Ages 6-11 Years - ACROFAN USA", "description": "Submission based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has submitted f\u2026", "url": "https://us.acrofan.com/detail.php?number=562466", "urlToImage": "https://mms.businesswire.com/media/20211109006033/en/839474/21/KO_LOGO.jpg", "publishedAt": "2021-11-08T20:32:00Z", "content": "Submission based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11\r\nCAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) ther\u2026 [+9706 chars]"}]}